Analysts Split Hard on Illumina and Rollins

The biggest target price moves today sit at opposite ends of the sentiment dial. Canaccord Genuity lifted its price target on ILMN by $95 to $300, a 46% jump in a single cut. The rating stays Hold, but the magnitude of the revision signals a meaningful re-rating of the genomics firm's outlook. Short interest at Illumina sits at 5.8% of free float, with availability above 645%, suggesting shorts are not crowded.

The same analyst house went the other way on ROL. Canaccord cut its Rollins target from $45 to $36, a 20% reduction, keeping a Hold. The pest control giant carries short interest of 9.2% of free float.

In financials, Truist lifted its target on TRV by $10 to $435 with a Buy, while Stephens trimmed RF and PNC targets modestly on Hold ratings. Canadian bank assets topping C$20 trillion for the first time on record in August points to a healthy lending backdrop for North American financials generally.

Jefferies raised its target on EL from $100 to $120, keeping Hold on the beauty group. Piper Sandler trimmed targets on both SLB and HAL while holding Buy ratings, reflecting softer near-term sentiment in oilfield services. Mizuho cut its EFX target sharply from $210 to $185, also maintaining Buy.

Wedbush nudged up its target on VRSN to $351.